Literature DB >> 26172576

Factors associated with inpatient hospitalizations among patients aged 1 to 64 years with congenital heart defects, Arkansas 2006 to 2011.

Regina M Simeone1, Matthew E Oster1,2, Charlotte A Hobbs3, James M Robbins3, R Thomas Collins3, Margaret A Honein1.   

Abstract

BACKGROUND: Individuals with congenital heart defects (CHDs) have high hospital resource use. We sought to identify factors associated with hospital costs and multiple hospitalizations among individuals with CHDs.
METHODS: Data from the 2006 to 2011 Healthcare Cost and Utilization Project Arkansas State Inpatient Databases were linked across encrypted patient identifiers to develop a cohort of Arkansas residents aged 1 to 64 years who were hospitalized at least once with a CHD during this time period. Infants were excluded because patient identifiers were missing for 18 to 52% each year. CHDs were identified using principal and secondary International Classification of Diseases, Ninth Revision, Clinical Modification diagnoses codes. All hospitalizations of individuals ever admitted with a CHD were included. Mean and median patient-level costs were estimated; the association of hospital costs and patient readmissions were examined with linear and logistic regression.
RESULTS: There were 1,185,868 inpatient hospitalizations of Arkansas residents aged 1 to 64 years between 2006 and 2011; these were accrued by 603,925 patients. Of those, 2542 patients (0.42%) had at least one hospitalization with a CHD diagnosis. Total costs for these 2542 patients were $126,999,837 and they accumulated 7898 hospitalizations. Factors associated with increased costs included patient age, CHD type, cardiac procedures, and comorbidities. Factors associated with hospital readmission within 1 year included age, CHD type, expected payer, and comorbidities.
CONCLUSION: Individuals with CHDs in Arkansas experience variation in hospital use and costs by patient characteristics. Future research should investigate factors associated with readmissions, cardiac procedures, and comorbidities, as these are strongly associated with hospital costs. Birth Defects Research (Part A) 103:589-596, 2015.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Arkansas; Congenital heart defects; Healthcare Cost and Utilization Project; One-year readmission; Person-level; hospital costs

Mesh:

Year:  2015        PMID: 26172576      PMCID: PMC4518202          DOI: 10.1002/bdra.23402

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  24 in total

1.  Task force 1: the changing profile of congenital heart disease in adult life.

Authors:  C A Warnes; R Liberthson; G K Danielson; A Dore; L Harris; J I Hoffman; J Somerville; R G Williams; G D Webb
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

2.  NCHS urban-rural classification scheme for counties.

Authors:  Deborah D Ingram; Sheila J Franco
Journal:  Vital Health Stat 2       Date:  2012-01

3.  Population-based study of hospital costs for hospitalizations of infants, children, and adults with a congenital heart defect, Arkansas 2006 to 2011.

Authors:  Regina M Simeone; Matthew E Oster; Charlotte A Hobbs; James M Robbins; R Thomas Collins; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-10

4.  Temporal trends in survival among infants with critical congenital heart defects.

Authors:  Matthew E Oster; Kyung A Lee; Margaret A Honein; Tiffany Riehle-Colarusso; Mikyong Shin; Adolfo Correa
Journal:  Pediatrics       Date:  2013-04-22       Impact factor: 7.124

5.  Strategies for implementing screening for critical congenital heart disease.

Authors:  Alex R Kemper; William T Mahle; Gerard R Martin; W Carl Cooley; Praveen Kumar; W Robert Morrow; Kellie Kelm; Gail D Pearson; Jill Glidewell; Scott D Grosse; R Rodney Howell
Journal:  Pediatrics       Date:  2011-10-10       Impact factor: 7.124

6.  Center variation in hospital costs for patients undergoing congenital heart surgery.

Authors:  Sara K Pasquali; Jie-Lena Sun; Phil d'Almada; Robert D B Jaquiss; Andrew J Lodge; Neal Miller; Alex R Kemper; Carole M Lannon; Jennifer S Li
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-04-19

7.  Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics.

Authors:  William T Mahle; Jane W Newburger; G Paul Matherne; Frank C Smith; Tracey R Hoke; Robert Koppel; Samuel S Gidding; Robert H Beekman; Scott D Grosse
Journal:  Circulation       Date:  2009-07-06       Impact factor: 29.690

8.  Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005.

Authors:  Mark D Reller; Matthew J Strickland; Tiffany Riehle-Colarusso; William T Mahle; Adolfo Correa
Journal:  J Pediatr       Date:  2008-07-26       Impact factor: 4.406

9.  The importance of nomenclature for congenital cardiac disease: implications for research and evaluation.

Authors:  Matthew J Strickland; Tiffany J Riehle-Colarusso; Jeffrey P Jacobs; Mark D Reller; William T Mahle; Lorenzo D Botto; Paige E Tolbert; Marshall L Jacobs; Francois G Lacour-Gayet; Christo I Tchervenkov; Constantine Mavroudis; Adolfo Correa
Journal:  Cardiol Young       Date:  2008-12       Impact factor: 1.093

10.  Pediatric inpatient hospital resource use for congenital heart defects.

Authors:  Regina M Simeone; Matthew E Oster; Cynthia H Cassell; Brian S Armour; Darryl T Gray; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-06-27
View more
  1 in total

Review 1.  Databases for Congenital Heart Defect Public Health Studies Across the Lifespan.

Authors:  Tiffany J Riehle-Colarusso; Lisa Bergersen; Craig S Broberg; Cynthia H Cassell; Darryl T Gray; Scott D Grosse; Jeffrey P Jacobs; Marshall L Jacobs; Russell S Kirby; Lazaros Kochilas; Asha Krishnaswamy; Arianne Marelli; Sara K Pasquali; Thalia Wood; Matthew E Oster
Journal:  J Am Heart Assoc       Date:  2016-10-26       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.